Top Articles
PAMA Cuts Averted Until ‘27; Labs Plan Next Move
Now the focus shifts to passing the RESULTS Act this year for a more permanent PAMA solution
CEO SUMMARY: Clinical laboratories have again avoided a potential financial disaster, at least for now, after Congress shifted PAMA cuts to test reimbursement rates until January 2027. However, the victory is temporary absent permanent PAMA reform. To that end, laboratory ...
Patient-Driven Testing Spurs New Opportunities
New survey results indicate 93% of consumers expect physicians to order lab tests upon request
CEO SUMMARY: Patient-driven diagnostic testing is creating both opportunities and challenges for clinical laboratories, as increased demand and evolving business models stretch the industry’s capacity and profitability. However, an industry veteran in commercial lab prod...
Boosting Path Revenue with POC Services
By providing value-added services, pathology group receives positive response to innovation
CEO SUMMARY: The concept sounds simple—bring mobile point-of-care pathology services to physician offices and ambulatory surgical centers via specially equipped vehicles. Doctors Pathology Services explains some of the road bumps it hit along the way while also uncoverin...
Lab Specimen Logistics Reach into the Home
Providers and vendors explain their strategies to accommodate consumer-driven demand
Simple, at-home collection of blood samples could go a long way toward improving the patient experience while creating new opportunities for clinical laboratories. But it also presents unique logistical challenges as labs find themselves operating in a more consu...
Elizabeth Holmes Seeks Trump Clemency for Conviction
The president has already set precedent for granting clemency to a healthcare exec sentenced for fraud
Elizabeth Holmes, the convicted former CEO of Theranos, is again drawing public attention as she seeks clemency from President Donald Trump, reviving interest in one of the most notorious fraud cases in Silicon Valley and clinical laboratory history. ...
Director Blissfully Uninvolved with Finances of DP Rollout
Vendor choice came down to an existing partnership within the wider organization
One of the biggest aspects of a clinical laboratory switching from traditional glass slides to digital pathology is the potential cost of such a project. It’s difficult to provide a reliable range of how expensive digital pathology (DP) imple...
Office of Inspector General Briefs
Congress Wants Review of Test Fraud As part of a spending bill approved by Congress recently, there is a small provision that hints at future review of clinical laboratory tests by the US Department of Health and Human Services’ Office of Inspector General (OIG)....
Permanent PAMA Reform Must Happen in 2026
Previously, it would have been hard to imagine even in the current political landscape that US immigration policy would so...
Don’t Be at the Mercy of the Tumultuous Healthcare Revolution
Subscribe to The Dark Report for as little as $15.27 per week.
Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.
CURRENT ISSUE
Volume XXXIII, No. 2 – February 9, 2026
Congress has once again delayed cuts to test reimbursement rates under PAMA, this time until Jan. 1, 2027. Laboratory professionals are urged to lobby Congress to pass the RESULTS act to solve the PAMA cuts problem permanently. Also, patient-driven testing is spurring new opportunities.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.